 | • レポートコード：MRC23Q35886 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の大腸がん分子診断学市場について調査・分析し、世界の大腸がん分子診断学市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他）、用途別セグメント分析（病院、第三者検査機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Roche Diagnostics、Abbott、Thermo Fisher、Qiagen、Illumina、Biomerieux、Bio-Rad、Agilent、Daangene、Amoydxなどが含まれています。世界の大腸がん分子診断学市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、大腸がん分子診断学市場規模を推定する際に考慮しました。本レポートは、大腸がん分子診断学の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、大腸がん分子診断学に関するビジネス上の意思決定に役立てることを目的としています。 ・大腸がん分子診断学市場の概要 - 大腸がん分子診断学のタイプ別セグメント - 世界の大腸がん分子診断学市場規模：タイプ別分析（ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他） - 大腸がん分子診断学の用途別セグメント - 世界の大腸がん分子診断学市場規模：用途別分析（病院、第三者検査機関、その他） - 世界の大腸がん分子診断学市場規模予測（2018年-2029年） ・大腸がん分子診断学市場の成長トレンド - 大腸がん分子診断学の地域別市場規模（2018年-2029年） - 大腸がん分子診断学市場ダイナミクス - 大腸がん分子診断学の業界動向 - 大腸がん分子診断学市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他 - 世界の大腸がん分子診断学のタイプ別市場規模（2018年-2023年） - 世界の大腸がん分子診断学のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、第三者検査機関、その他 - 世界の大腸がん分子診断学の用途別市場規模（2018年-2023年） - 世界の大腸がん分子診断学の用途別市場規模（2024年-2029年） ・大腸がん分子診断学の地域別市場規模 - 北米の大腸がん分子診断学市場規模（2018年-2029年） - アメリカの大腸がん分子診断学市場規模（2018年-2029年） - ヨーロッパの大腸がん分子診断学市場規模（2018年-2029年） - アジア太平洋の大腸がん分子診断学市場規模（2018年-2029年） - 中国の大腸がん分子診断学市場規模（2018年-2029年） - 日本の大腸がん分子診断学市場規模（2018年-2029年） - 韓国の大腸がん分子診断学市場規模（2018年-2029年） - インドの大腸がん分子診断学市場規模（2018年-2029年） - オーストラリアの大腸がん分子診断学市場規模（2018年-2029年） - 中南米の大腸がん分子診断学市場規模（2018年-2029年） - 中東・アフリカの大腸がん分子診断学市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Roche Diagnostics、Abbott、Thermo Fisher、Qiagen、Illumina、Biomerieux、Bio-Rad、Agilent、Daangene、Amoydx ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Colorectal Cancer Molecular Diagnostics market was valued at US$ 684.5 million in 2022 and is anticipated to reach US$ 1515 million by 2029, witnessing a CAGR of 14.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics.
The Colorectal Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Colorectal Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Segment by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Segment by Application
Hospital
Third-Party Testing Agency
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polymerase Chain Reaction PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Third-Party Testing Agency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2018-2029)
2.2 Colorectal Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Colorectal Cancer Molecular Diagnostics Market Dynamics
2.3.1 Colorectal Cancer Molecular Diagnostics Industry Trends
2.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
2.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
2.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Molecular Diagnostics Revenue
3.4 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Revenue in 2022
3.5 Colorectal Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
5 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
6.2 North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
6.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
7.2 Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
7.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
9.2 Latin America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.3.5 Thermo Fisher Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
11.4.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.4.5 Qiagen Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Introduction
11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 Biomerieux
11.6.1 Biomerieux Company Detail
11.6.2 Biomerieux Business Overview
11.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Introduction
11.6.4 Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.6.5 Biomerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Introduction
11.7.4 Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.7.5 Bio-Rad Recent Development
11.8 Agilent
11.8.1 Agilent Company Detail
11.8.2 Agilent Business Overview
11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.8.5 Agilent Recent Development
11.9 Daangene
11.9.1 Daangene Company Detail
11.9.2 Daangene Business Overview
11.9.3 Daangene Colorectal Cancer Molecular Diagnostics Introduction
11.9.4 Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.9.5 Daangene Recent Development
11.10 Amoydx
11.10.1 Amoydx Company Detail
11.10.2 Amoydx Business Overview
11.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Introduction
11.10.4 Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.10.5 Amoydx Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
